SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 2,244.13 |
| Enterprise Value ($M) | 2,017.38 |
| Book Value ($M) | 1,050.17 |
| Book Value / Share | 10.89 |
| Price / Book | 2.14 |
| NCAV ($M) | 747.52 |
| NCAV / Share | 7.75 |
| Price / NCAV | 3.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.67 |
| Current Ratio | 8.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 998.33 |
| Assets | 1,300.98 |
| Liabilities | 250.81 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 36.27 |
| Operating Income | -515.29 |
| Net Income | -481.19 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -394.09 |
| Cash from Investing | -31.35 |
| Cash from Financing | 130.32 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.32 | 6.88 | |
| 13G/A | ARK Investment Management LLC | 12.74 | 21.14 | |
| 13G/A | State Street Corp | 5.29 | 179.65 | |
| 13G/A | BlackRock Inc. | 10.10 | 24.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 185,955 | 1,294,988 | 14.36 | |
| 246,409 | 396,653 | 62.12 | |
| 310,998 | 725,628 | 42.86 | |
| 171,707 | 589,980 | 29.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NGNE – Neurogene Inc. | NKGN – NKGen Biotech, Inc. |
| NRIX – Nurix Therapeutics, Inc. | OCS – Oculis Holding AG |
| OCUL – Ocular Therapeutix, Inc. |
Financial data and stock pages provided by
Fintel.io